Trial intelligence / Profile preview

Ketamine-midazolam for emergence agitation in children

NCT02022488Phase 4Completed

Sponsor
Yeditepe University Hospital
Start
Feb 2012
Primary completion
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ketamine and alfentanil in Emergence agitation (EA), sponsored by Yeditepe University Hospital. Primary endpoint: Pediatric Anesthesia Emergence Delirium at 7 months. Started Feb 2012; status: completed.

02

Drugs

ketaminealfentanil
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT02022488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02022488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call